Editorial: Kinase inhibitors in cancer therapy
- PMID: 36393866
- PMCID: PMC9660224
- DOI: 10.3389/fcell.2022.1020297
Editorial: Kinase inhibitors in cancer therapy
Keywords: Bax/Bcl-2; EGFR pathway; RAS-RAF-MEK-ERK pathway; RET = rearranged during transfection; kinase inhibitors.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Kinase inhibitors in cancer therapy
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
